Decoy Therapeutics Inc.
DCOY | NASDAQ
$1.07
-$0.16 (-13.01%)
At close: Oct 30, 2026, 4:00 PM ET
$1.08
+$0.01 (+0.95%)
Pre-market:
Nov 2, 2026, 8:24 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.30 | -3.81 | -2.03 | -1.23 | -19.27 | -23.14 |
PEG Ratio | 0 | 0.05 | 0.03 | -0.01 | 0.56 | 0.30 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 32.50 |
PB Ratio | 0.64 | 14.05 | 4.82 | 3.76 | 6.35 | 7.68 |
P/FCF Ratio | -0.78 | -4.69 | -1.98 | -2.04 | -24.12 | -16.49 |
P/OCF Ratio | -0.78 | -4.69 | -1.98 | -2.22 | -24.12 | -16.50 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -197.03 |
Debt / Equity Ratio | n/a | 0.15 | 0.05 | n/a | n/a | 0.02 |
Quick Ratio | 2.13 | 1.98 | 5.02 | 3.40 | 14.29 | 5.70 |
Current Ratio | 2.13 | 1.98 | 5.02 | 3.40 | 14.29 | 5.70 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.21 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -2.56K |
Return on Equity | -212.58% | -368.84% | -237.22% | -304.37% | -32.97% | -33.18% |
Return on Assets | -113.22% | -184.45% | -190.43% | -215.74% | -31.27% | -29.49% |
Return on Invested Capital | -214.20% | -330.78% | -231.22% | -306.62% | -33.09% | -34.40% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 100% |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -140.49% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -140.49% |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -148.78% |
FCF Margin | n/a | n/a | n/a | n/a | n/a | -197.08% |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -145.09% |
Add to Watchlist
Select watchlists to add or remove DCOY